Clinical Presentations, Microbiology, Antibiotic Resistance Patterns and Management Outcomes of Culture-proven Infection Among Adolescent and Adult in A Tertiary Hospital in Saudi Arabia
NCT04395586 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-01-03
Summary
The characteristics of patients as well as microbiologic profile of culture-proven infection will be studies in conjunction with clinical outcome within 28-days
Conditions
- Culture-proven Infection
Interventions
- OTHER
-
Culture
Culture
Sponsors & Collaborators
-
Aseer Central Hospital
lead OTHER_GOV
Principal Investigators
-
Abdullah M Algarni, MBBS · Aseer Central Hospital
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2021-06-30
- Completion
- 2021-06-30
More Related Trials
-
Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique
NCT03583762 ·Status: UNKNOWN ·Phase: NA
-
Point-of-Care Multiplex for Adult Patients With Severe Community-acquired Pneumonia
NCT04835818 ·Status: UNKNOWN ·Phase: NA
-
Pathogenic Microorganisms in Adult Severe Pneumonia Patients
NCT04433403 ·Status: UNKNOWN
-
Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
NCT00140023 ·Status: COMPLETED ·Phase: PHASE3
-
Computerized Antibiotic Stewardship Study
NCT03120975 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
NCT04681339 ·Status: RECRUITING
-
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
NCT01940731 ·Status: UNKNOWN ·Phase: PHASE2
-
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
NCT04333589 ·Status: UNKNOWN ·Phase: NA
-
Improved Use of Antibiotic Guidelines in Hospital Environment
NCT00512772 ·Status: COMPLETED
-
Outcomes in Hospitalized Older Patients With COVID-19
NCT04385212 ·Status: COMPLETED
-
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
NCT05903352 ·Status: RECRUITING ·Phase: PHASE3
-
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
NCT07164131 ·Status: RECRUITING ·Phase: PHASE4
-
ADEQUATE Advanced Diagnostics for Enhanced Quality of Antibiotic Prescription
NCT04547556 ·Status: TERMINATED ·Phase: NA
-
Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy
NCT00323986 ·Status: TERMINATED ·Phase: PHASE2
-
Project to Improve the Diagnosis and Treatment Ability of Adult Severe Community Acquired Lower Respiratory Tract Infection
NCT04959955 ·Status: COMPLETED
-
Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia
NCT06112938 ·Status: COMPLETED
-
DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia
NCT03360851 ·Status: TERMINATED ·Phase: NA
-
Surveillance of Healthcare-associated Infections & Antimicrobial Resistance
NCT05734391 ·Status: ENROLLING_BY_INVITATION
-
Standardized Clinical Application of Antibacterial/Anitifungal Drugs
NCT04966390 ·Status: UNKNOWN
-
Antibiotic Therapy in Viral Airway Infections
NCT05045612 ·Status: RECRUITING ·Phase: PHASE4
-
Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years
NCT00843895 ·Status: UNKNOWN ·Phase: NA
-
Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy
NCT01819298 ·Status: COMPLETED
-
Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients
NCT04674410 ·Status: WITHDRAWN
-
Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19
NCT04359706 ·Status: COMPLETED
-
The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens
NCT07035535 ·Status: ENROLLING_BY_INVITATION